Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (2872)	6/4/2010 10:29:10 PM
From: Jibacoa	1 Recommendation Read Replies (1) \| Respond to of 3722

ARWR has continued to do well.<g> The stock was up 9.47% and continued to gain some AHs. Volume of 1,570,241 was > 200Ks above its ADV bigcharts.marketwatch.com When ARWR was drifting down from the spike on March 22, I took the chance of recommending it to my barber, who has been interested on the market lately and was asking for some tips.<g> Come to think of it, that was a risky move on my part, since after all, he many times holds a rather sharp razor around my head.<g> But since he bought around $0.85 I know that I am safe and don't have to worry about it. However, I think that I should better avoid answering any such questions from him in the future.<g> As mentioned, the ACTAY remains at $9 I will keep my target at $3 and will resist temptation of buying any more, since I already have more than I should for my age.<g> bigcharts.marketwatch.com Bernard